High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure.
Summary What is known and Objective: The increased central sympathetic activity typically associated with chronic heart failure (CHF) is probably mediated by formation of reactive oxygen species (ROS) in the brain. Our objective was to undertake a trial to test our hypothesis that administration of...
| Published in: | Journal of Clinical Pharmacy & Therapeutics Vol. 36; no. 5; pp. 546 - 553 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | research tables/charts randomized controlled trial Journal Article |
| Published: |
Wiley-Blackwell
Oct2011
|
| Online Access: | View this record in EBSCOhost |